InvestorsObserver
×
News Home

Do Analysts Expect Zogenix, Inc. (ZGNX) Stock to Rise After It Is Lower By -25.44% in a Month?

Monday, November 29, 2021 03:39 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Expect Zogenix, Inc. (ZGNX) Stock to Rise After It Is Lower By -25.44% in a Month?

Wall Street is positive on Zogenix, Inc. (ZGNX). On average, analysts give Zogenix, Inc. a Strong Buy rating. The average price target is $33, which means analysts expect the stock to rise by 187.21% over the next twelve months. That average ranking earns Zogenix, Inc. an Analyst Rating of 59, which is better than 59% of stocks based on data compiled by InvestorsObserver.

Overall Score - 4.6
Wall Street analysts are rating ZGNX a Strong Buy today. Find out what this means to you and get the rest of the rankings on ZGNX!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers. InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Zogenix, Inc. Stock Today?

Zogenix, Inc. (ZGNX) stock is lower by -1.79% while the S&P 500 is up 1.55% as of 3:23 PM on Monday, Nov 29. ZGNX is down -$0.21 from the previous closing price of $11.70 on volume of 469,277 shares. Over the past year the S&P 500 is higher by 28.83% while ZGNX is down -46.38%. ZGNX lost -$4.35 per share the over the last 12 months. Click Here to get the full Stock Report for Zogenix, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App